243 related articles for article (PubMed ID: 10970775)
1. Overexpression of antizyme in the hearts of transgenic mice prevents the isoprenaline-induced increase in cardiac ornithine decarboxylase activity and polyamines, but does not prevent cardiac hypertrophy.
Mackintosh CA; Feith DJ; Shantz LM; Pegg AE
Biochem J; 2000 Sep; 350 Pt 3(Pt 3):645-53. PubMed ID: 10970775
[TBL] [Abstract][Full Text] [Related]
2. Targeted overexpression of ornithine decarboxylase enhances beta-adrenergic agonist-induced cardiac hypertrophy.
Shantz LM; Feith DJ; Pegg AE
Biochem J; 2001 Aug; 358(Pt 1):25-32. PubMed ID: 11485548
[TBL] [Abstract][Full Text] [Related]
3. Overproduction of cardiac S-adenosylmethionine decarboxylase in transgenic mice.
Nisenberg O; Pegg AE; Welsh PA; Keefer K; Shantz LM
Biochem J; 2006 Jan; 393(Pt 1):295-302. PubMed ID: 16153183
[TBL] [Abstract][Full Text] [Related]
4. Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis.
Feith DJ; Shantz LM; Pegg AE
Cancer Res; 2001 Aug; 61(16):6073-81. PubMed ID: 11507056
[TBL] [Abstract][Full Text] [Related]
5. Polyamine regulation of ornithine decarboxylase and its antizyme in intestinal epithelial cells.
Yuan Q; Ray RM; Viar MJ; Johnson LR
Am J Physiol Gastrointest Liver Physiol; 2001 Jan; 280(1):G130-8. PubMed ID: 11123206
[TBL] [Abstract][Full Text] [Related]
6. Regulation of ornithine decarboxylase activity and polyamine transport by agmatine in rat pulmonary artery endothelial cells.
Babál P; Ruchko M; Campbell CC; Gilmour SP; Mitchell JL; Olson JW; Gillespie MN
J Pharmacol Exp Ther; 2001 Feb; 296(2):372-7. PubMed ID: 11160620
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mouse models for studies of the role of polyamines in normal, hypertrophic and neoplastic growth.
Pegg AE; Feith DJ; Fong LY; Coleman CS; O'Brien TG; Shantz LM
Biochem Soc Trans; 2003 Apr; 31(2):356-60. PubMed ID: 12653638
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S
Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931
[TBL] [Abstract][Full Text] [Related]
9. Forced expression of antizyme abolishes ornithine decarboxylase activity, suppresses cellular levels of polyamines and inhibits cell growth.
Murakami Y; Matsufuji S; Miyazaki Y; Hayashi S
Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):183-7. PubMed ID: 7998932
[TBL] [Abstract][Full Text] [Related]
10. L-arginine inhibits isoproterenol-induced cardiac hypertrophy through nitric oxide and polyamine pathways.
Lin Y; Wang LN; Xi YH; Li HZ; Xiao FG; Zhao YJ; Tian Y; Yang BF; Xu CQ
Basic Clin Pharmacol Toxicol; 2008 Aug; 103(2):124-30. PubMed ID: 18816294
[TBL] [Abstract][Full Text] [Related]
11. Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression.
Nilsson J; Grahn B; Heby O
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):699-704. PubMed ID: 10698696
[TBL] [Abstract][Full Text] [Related]
12. Early alterations of polyamine metabolism induced after acute administration of clenbuterol in mouse heart.
Cubría JC; Ordóñez C; Reguera RM; Tekwani BL; Balaña-Fouce R; Ordóñez D
Life Sci; 1999; 64(19):1739-52. PubMed ID: 10353628
[TBL] [Abstract][Full Text] [Related]
13. Isoprenaline induced changes in ornithine decarboxylase activity and polyamine content in regions of the rat heart.
Tipnis UR; Frasier-Scott K; Skiera C
Cardiovasc Res; 1989 Jul; 23(7):611-9. PubMed ID: 2598215
[TBL] [Abstract][Full Text] [Related]
14. Polyamines regulate both transcription and translation of the gene encoding ornithine decarboxylase antizyme in mouse.
Nilsson J; Koskiniemi S; Persson K; Grahn B; Holm I
Eur J Biochem; 1997 Dec; 250(2):223-31. PubMed ID: 9428668
[TBL] [Abstract][Full Text] [Related]
15. Regulation of ornithine decarboxylase by antizymes and antizyme inhibitor in zebrafish (Danio rerio).
Hascilowicz T; Murai N; Matsufuji S; Murakami Y
Biochim Biophys Acta; 2002 Oct; 1578(1-3):21-8. PubMed ID: 12393184
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding.
Almrud JJ; Oliveira MA; Kern AD; Grishin NV; Phillips MA; Hackert ML
J Mol Biol; 2000 Jan; 295(1):7-16. PubMed ID: 10623504
[TBL] [Abstract][Full Text] [Related]
17. Control of ornithine decarboxylase activity by polyamines and absence of antizyme in Tetrahymena.
Koguchi K; Murakami Y; Hayashi S
Comp Biochem Physiol B Biochem Mol Biol; 1996 Jan; 113(1):157-62. PubMed ID: 8936049
[TBL] [Abstract][Full Text] [Related]
18. Systemic overexpression of antizyme 1 in mouse reduces ornithine decarboxylase activity without major changes in tissue polyamine homeostasis.
Pietilä M; Dhungana H; Uimari A; Sironen R; Alhonen L
Transgenic Res; 2014 Feb; 23(1):153-63. PubMed ID: 24174210
[TBL] [Abstract][Full Text] [Related]
19. Identification of regulatory region of antizyme necessary for the negative regulation of polyamine transport.
Sakata K; Fukuchi-Shimogori T; Kashiwagi K; Igarashi K
Biochem Biophys Res Commun; 1997 Sep; 238(2):415-9. PubMed ID: 9299523
[TBL] [Abstract][Full Text] [Related]
20. Nuclear translocation of antizyme and expression of ornithine decarboxylase and antizyme are developmentally regulated.
Gritli-Linde A; Nilsson J; Bohlooly-Y M; Heby O; Linde A
Dev Dyn; 2001 Mar; 220(3):259-75. PubMed ID: 11241834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
